Literature DB >> 17336069

Paraneoplastic myopathy: response to intravenous immunoglobulin.

J B Sampson1, S M Smith, A G Smith, J R Singleton, S Chin, A Pestronk, K M Flanigan.   

Abstract

Necrotizing myopathy is an unusual and severe form of paraneoplastic myopathy in which inflammation is minimal or absent. We report two cases of necrotizing myopathy which demonstrated significant response to intravenous immunoglobulin (IVIG) (one in spite of tumor progression). A third case represents the first association of anti-signal recognition particle (anti-SRP) syndrome with large-cell lung cancer. These cases highlight the role of histopathologic diagnosis in directing the treatment of paraneoplastic myopathy, and the role for IVIG in treatment of the syndrome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17336069     DOI: 10.1016/j.nmd.2007.01.004

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  12 in total

1.  Unusual manifestations in two cases of necrotizing myopathy associated with SRP antibodies.

Authors:  F Hanisch; T Müller; G Stoltenburg; S Zierz
Journal:  Rheumatol Int       Date:  2011-12-27       Impact factor: 2.631

2.  Cancer-associated myositis associated with oesophageal adenocarcinoma arising in Barrett's oesophagus without serum myogenic enzymes elevation: an example suggesting the importance of MRI.

Authors:  Yosuke Sasaki; Hiroshige Shimizu; Tetsuo Nemoto; Yoshihisa Urita
Journal:  BMJ Case Rep       Date:  2016-04-21

Review 3.  Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.

Authors:  Pari Basharat; Lisa Christopher-Stine
Journal:  Curr Rheumatol Rep       Date:  2015-12       Impact factor: 4.592

4.  Proteomic expression analysis of surgical human colorectal cancer tissues: up-regulation of PSB7, PRDX1, and SRP9 and hypoxic adaptation in cancer.

Authors:  Jung-hyun Rho; Shuzhen Qin; Julia Y Wang; Michael H A Roehrl
Journal:  J Proteome Res       Date:  2008-06-13       Impact factor: 4.466

5.  Can cetuximab affect paraneoplastic myopathy?

Authors:  Eleni Galani; Anastasios Bonakis; Christos Christodoulou; George Klouvas; Angeliki Drougou; Drougou Angeliki; Dimostenis Skarlos
Journal:  J Neurooncol       Date:  2009-01-22       Impact factor: 4.130

6.  Complex repetitive discharge on electromyography as a risk factor for malignancy in idiopathic inflammatory myopathy.

Authors:  Na Ri Kim; Eon Jeong Nam; Jong Wan Kang; Hyun Seok Song; Churl Hyun Im; Young Mo Kang
Journal:  Korean J Intern Med       Date:  2014-10-31       Impact factor: 2.884

7.  A mild form of dermatomyositis as a prodromal sign of lung adenocarcinoma: a case report.

Authors:  Eleni Papakonstantinou; Alexander Kapp; Ulrike Raap
Journal:  J Med Case Rep       Date:  2016-02-06

8.  Paraneoplastic Necrotizing Autoimmune Myopathy in a Patient Undergoing Laparoscopic Pancreatoduodenectomy for Distal Cholangiocarcinoma.

Authors:  Stefan van Dijk; Anneke J van der Kooi; Eleonora Aronica; Thomas M van Gulik; Olivier R Busch; Marc G Besselink
Journal:  Case Rep Gastroenterol       Date:  2016-10-06

9.  Paraneoplastic Necrotizing Myopathy with a Mild Inflammatory Component: A Case Report and Review of the Literature.

Authors:  Susanne Wegener; Juliane Bremer; Paul Komminoth; Hans H Jung; Michael Weller
Journal:  Case Rep Oncol       Date:  2010-04-08

10.  Paraneoplastic necrotizing myopathy associated with adenocarcinoma of the lung - a rare entity with atypical onset: a case report.

Authors:  Angela Acciavatti; Tiziana Avolio; Simone Rappuoli; Luca Foderi; Vittoria Soldati; Massimo Franchi; Nila Volpi; Ranuccio Nuti
Journal:  J Med Case Rep       Date:  2013-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.